7. Glucocorticoids have broad anti-inflammatory effects on multiple components of cellular
immunity.
MOA –
To effect longer-term responses, steroids bind to receptors inside cells; either these
receptors, glucocorticoid-induced proteins, or interacting proteins regulate the
transcription of numerous other genes
Glucocorticoids lyse and induce the redistribution of lymphocytes,
Curtail activation of NF-КB, which increases apoptosis of activated cells, key pro-
inflammatory cytokines such as IL-1 and IL-6 are downregulated.
T cells are inhibited from making IL-2 and proliferating.
The activation of cytotoxic T lymphocytes is inhibited.
Neutrophils and monocytes display poor chemotaxis and decreased lysosomal enzyme
release.
8. combined with other immunosuppressive agents to prevent and treat
transplant rejection.
graft-versus-host disease in bone-marrow transplantation.
Glucocorticoids are routinely used to treat auto-immune disorders such
as
RA
SLE, psoriasis
Asthma and other allergic disorders,
inflammatory bowel disease
acute exacerbations of MS (see "Multiple Sclerosis").
to block first-dose cytokine storm caused by treatment with
muromonab-CD3 and to a lesser extent ATG
9. Growth retardation in children,
Avascular necrosis of bone, osteopenia
Increased risk of infection
Poor wound healing
Cataracts
Hyperglycemia
Hypertension
The advent of combined glucocorticoid + calcineurin inhibitor regimens
has allowed reduced doses or rapid withdrawal of steroids, resulting in
lower steroid-induced morbidities.
10. Perhaps the most effective immunosuppressive drugs
in routine use
They target intracellular signalling pathways induced as
a consequence of T cell–receptor activation
Tacrolimus Cyclosporine
11.
12. PK-
• Variable
• Trough level correlates better with clinical events
(100-200 ng/mL )
• The t 1/2 of tacrolimus is 12 hours
• CYP3A4
USE –
• prophylaxis of solid-organ allograft rejection
• GVHD
Tacrolimus (FK506) is a macrolide antibiotic produced by
Streptomyces tsukubaensis
13. Nephrotoxicity,
Neurotoxicity (e.g., tremor, headache, motor
disturbances, seizures),
GI complaints,
hypertension,
hyperkalemia,
Hyperglycemia and diabetes
14. PK-
• 20-50% bioavailability
• CYP3A4
USE –
• Clinical indications for cyclosporine are kidney, liver, heart,
and other organ transplantation
• Rheumatoid arthritis and psoriasis.
Cyclosporine, a cyclic polypeptide of 11 amino acids, is produced by
the fungus Beauveria nivea
16. PK-
• Systemic availability is 15%
• A loading dose of three times the
maintenance dose will provide
nearly steady-state
• CYP3A4
USE –
• Prophylaxis of organ transplant
rejection usually in combination
• At risk of calcineurin inhibitor–
associated nephrotoxicity
Sirolimus is a macrocyclic lactone produced by Streptomyces
hygroscopicus
MOA
17. dose-dependent increase in serum cholesterol
Lymphocele, a known surgical complication associated with renal
transplantation
cyclosporine and sirolimus interact, and their administration
should be separated by time
Everolimus
chemically and clinically related to sirolimus but has distinct
pharmacokinetics.
The main difference is a shorter t1/2 and thus a shorter time to
achieve steady-state concentrations of the drug.
18. It is an imidazolyl derivative of 6-mercaptopurine
MOA –
cleaved to 6-mercaptopurine (via Glutathione),
A fraudulent nucleotide, 6-thio-IMP, is converted to 6-
thio-GMP and finally to 6-thio-GTP, which is
incorporated into DNA.
converted to additional metabolites that inhibit de
novo purine synthesis
Cell proliferation thereby is inhibited, impairing a
variety of lymphocyte functions.
19. PK –
Well absorbed orally
T1/2 = 10 mins (active metabolites)
USE-
adjunct for prevention of organ transplant rejection
Severe RA
ADR –
The major side effect of azathioprine is bone marrow suppression
increased susceptibility to infections (HSV),
hepatotoxicity, alopecia, GI toxicity, pancreatitis,
20. It is an ester of mycophenolic acid (MPA).
MOA –
MMF is a prodrug that is rapidly
hydrolyzed to the active drug, MPA
MPA - a selective, noncompetitive,
reversible inhibitor of inosine
monophosphate dehydrogenase (IMPDH),
IMPDH is an enzyme @ de novo pathway
of guanine nucleotide synthesis
B and T lymphocytes are highly
dependent on this pathway for cell
proliferation (others- salvage pathway)
21. PK –
The parent drug - within a few minutes. The t1/2 of MPA is 16 hours.
T1/2 = 10 mins (active metabolites)
USE-
MMF is indicated for prophylaxis of transplant rejection, and it
typically is used in combination (Glucocorticoid/Calcineurin)
off label - SLE
ADR –
Gut -
Hematologic – PRCA, leucopenia
Congenital anomaly